Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01060072 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
A Phase 3 study of Pain and Inflammation, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 3
- Development phase
- 407
- Enrollment target
- 1
- Study location
NCT01060072: Completed Phase 3 study of Pain and Inflammation, sponsored by Bausch & Lomb Incorporated.
NCT01060072 is a Phase 3 study of Pain and Inflammation that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 407 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01060072, a Phase 3 study of Pain and Inflammation, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 407 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to compare the safety and efficacy of loteprednol etabonate to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.
Primary Outcome
Participants with complete resolution of anterior chamber cells(ACC). Cells were graded on a 0-4 scale, where 0=no cells and 4=\>30 cells
Conditions Studied
Interventions
- DRUG Loteprednol etabonate
- DRUG Vehicle of Loteprednol Etabonate
Study Locations (1)
New York
- Bausch & Lomb - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 407 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-10 |
| Phase | Phase 3 |
What the finished NCT01060072 record still lists
NCT01060072 is an interventional study that assigns participants to a tested intervention. The registered 407 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (34% higher).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Loteprednol etabonate is the first listed.
NCT01060072 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01060072 about?
NCT01060072 is a clinical study titled "Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery". This study is being conducted to compare the safety and efficacy of loteprednol etabonate to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.
What is the current status of trial NCT01060072?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 407 participants. The study started on 2010-02. Estimated completion is 2010-10.
What conditions does trial NCT01060072 study?
This clinical trial studies the following conditions: Pain, Inflammation.
What interventions are being tested in trial NCT01060072?
The interventions under investigation include: Loteprednol etabonate (DRUG), Vehicle of Loteprednol Etabonate (DRUG).
Who is sponsoring clinical trial NCT01060072?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01060072 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01060072's enrollment target sits among peer trials
407 45th of 374 higher than 330 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
- NCT07094516 · 407 participants · Phase 2
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- NCT04835428 · 408 participants · NA
STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures
- NCT05836324 · 408 participants · Phase 1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia